IP Library Granted Patent US 8,968,768
Granted Patent B2
US 8,968,768 · App. 11/236,570 · Granted Mar 3, 2015

Phytosterol nutritional supplements

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,968,768
App. No.
11/236,570
Granted
Mar 3, 2015
Kind
B2
Abstract

The invention provides a nutritional supplement which includes phytosterol to facilitate reduction of cholesterol. The nutritional supplement may be a swallowable tablet, chewable tablet, sachet, capsule or suspension. The invention further provides a method for tableting one fourth to one half of the daily effective dosage of a phytosterol containing nutritional supplement in a practical sized swallowable tablet and a method for reducing blood cholesterol in humans.

Claims (20)

1. An immediate release nutritional supplement for administration to humans comprising: an effective amount of phytosterol and a second element; wherein the phytosterol is mixed with at least part of the second element prior to blending with other suitable ingredients, resulting in a phytosterol that is at least partially coated with the second element; wherein the second element consists of at least one absorbent and the at least one absorbent comprises silicon dioxide; wherein the nutritional supplement is a swallowable tablet; and wherein there are no surfactants in the tablet of the nutritional supplement.

2. The immediate release nutritional supplement of claim 1 , wherein the second element further comprises calcium silicate, talc, titanium dioxide, and combinations thereof.

3. The nutritional supplement of claim 1 , wherein the tablet is coated with a film coating comprising polyvinyl alcohol.

4. A method of a nutritional supplementation for a human which facilitates reduction of serum cholesterol comprising providing a human an effective amount of the nutritional supplement of claim 1 .

5. A method of tableting an immediate release phytosterol containing nutritional supplement, said method comprising: providing at least one phytosterol; forming phytosterol particulates of a suitable particle size; mixing the phytosterol particulates with a second element prior to blending other suitable ingredients with the phytosterol particulates; and then tableting the blend; wherein the second element consists of at least one absorbent and the at least one absorbent comprises silicon dioxide; and wherein there are no surfactants in the tablet of the nutritional supplement.

6. The method of claim 5 wherein the tableted immediate release phytosterol further comprises a diluent, wherein at least a portion of the diluent is selected from a calcium compound and a magnesium compound or a mixture thereof.

7. The method of claim 5 wherein the second element further comprises

calcium silicate, talc, titanium dioxide, and combinations thereof.

8. The method of claim 5 , said method further comprising film coating the tablet.

9. An immediate release phytosterol containing

nutritional supplement prepared by the process comprising the steps of:

(a) providing at least one phytosterol;

(b) forming phytosterol particulates of a suitable particle size;

(c) mixing the phytosterol particulates with a second element prior to step (d);

(d) blending other suitable ingredients with the phytosterol particulates of step (c);

and then

(e) tableting the blend of step (d);

wherein the second element consists of at least one absorbent and the at least one absorbent comprises silicon dioxide: and wherein there are no surfactants in the tablet of the nutritional supplement.

10. The nutritional supplement of claim 9 wherein the tableted immediate release phytosterol further comprises a diluent, wherein at least a portion of the diluent is selected from a calcium compound and a magnesium compound or a mixture thereof.

11. The nutritional supplement of claim 9 wherein the second element further comprises calcium silicate, talc, titanium dioxide, and combinations thereof.

Assignments (6)
CHANGE OF NAME Recorded Mar 1, 2024
From: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: HALEON US HOLDINGS LLC
Reel/Frame 066713/0558 →
CHANGE OF NAME Recorded Feb 28, 2024
From: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: HALEON US HOLDINGS LLC
Reel/Frame 066701/0387 →
MERGER AND CHANGE OF NAME Recorded Apr 6, 2022
From: PF CONSUMER HEALTHCARE 1 LLC; GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
To: GLAXOSMITHKLINE CONSUMER HEALTHCARE HOLDINGS (US) LLC
Reel/Frame 059620/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2019
From: WYETH LLC
To: PF CONSUMER HEALTHCARE 1 LLC
Reel/Frame 050727/0184 →
CHANGE OF NAME Recorded May 2, 2011
From: WYETH
To: WYETH LLC
Reel/Frame 026210/0652 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2005
From: BUBNIS, WILLIAM; POXON, SCOTT W.; SUTTON, BRUCE W.; VERNON, JEFFREY V.; WALTERS, DENISE L.; WILLIAMS, MICHAEL G.; WITTENBERG, NEIL
To: WYETH
Reel/Frame 017123/0833 →